| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 06/15/1999 | US5912360 Dioxolane intermediates |
| 06/15/1999 | US5912335 A polynucleotide sequence that codes human 7-transmembrane receptor protein; treatment of infections, hiv, eating disorders, cancers, heart diseases, mental illnesses, huntington's disease, tourett's and parkinson's disease |
| 06/15/1999 | US5912270 Anti-inflammatory compounds |
| 06/15/1999 | US5912262 Heterocyclic compounds |
| 06/15/1999 | US5912251 Metabolically inert anti-inflammatory and anti-tumor antifolates |
| 06/15/1999 | US5912232 Administering peptides having antagonist activity for alpha chemokines, for treatment of autoimmune and inflammatory disorders |
| 06/15/1999 | US5912144 A polypeptide having an amino acid sequence for an immediate early response gene/g protein couplec receptor; anticarcinogenic, antiproliferative and antitumor agents |
| 06/15/1999 | US5912011 Solvent system to be enclosed in capsules |
| 06/15/1999 | US5911997 Relaxin-like factor and methods and uses thereof |
| 06/15/1999 | US5911984 Disorders associated with fatty acid metabolism. |
| 06/15/1999 | CA2155664C Oxindole 1-[n-(alkoxycarbonyl)]carboxamides and 1-(n-carboxamido)carboxamides as antiinflammatory agents |
| 06/15/1999 | CA2136821C Quaternary nitrogen-containing phosphonate compounds for treating abnormal calcium and phosphate metabolism |
| 06/10/1999 | WO1999028492A1 A method of finding agonist and antagonist to human 11cb splice variant |
| 06/10/1999 | WO1999028359A1 Preparation for prevention and healing of inflammation affections |
| 06/10/1999 | WO1999028344A2 Synthetic peptides containing citrulline recognized by rheumatoid arthritis sera as tools for diagnosis and treatment |
| 06/10/1999 | WO1999028304A2 Pdgf receptor kinase inhibitory compounds, their preparation and compositions |
| 06/10/1999 | WO1999027962A1 Use of a fibrinogen receptor-antagonist for preventing disseminated intravascular coagulation |
| 06/10/1999 | WO1999027924A2 Fatty acid uninterrupted by a methylene as anti-inflammatory agents in superficial tissues of mammals |
| 06/10/1999 | WO1999027890A2 A process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs |
| 06/10/1999 | WO1999004765A3 Pharmaceutical compositions containing an effervescent acid-base couple |
| 06/10/1999 | DE19753383A1 Verwendung von Abciximab zur Behandlung von Mikrozirkulationsstörungen Use of abciximab for treatment of microcirculatory disorders |
| 06/10/1999 | CA2312824A1 Use of a fibrinogen receptor-antagonist for preventing disseminated intravascular coagulation |
| 06/10/1999 | CA2312749A1 Pdgf receptor kinase inhibitory compounds and compositions, method for synthesis of same and use of same for treatment of proliferate disorders |
| 06/10/1999 | CA2309534A1 Synthetic peptides containing citrulline recognized by rheumatoid arthritis sera as tools for diagnosis and treatment |
| 06/09/1999 | EP0921197A2 Human disintegrin metalloprotease related to drosophila kuz gene |
| 06/09/1999 | EP0921119A1 Pyrrole derivatives, process for their preparation and pharmaceutical compositions containing them |
| 06/09/1999 | EP0920869A1 Stable aspirin-containing preparations for external use |
| 06/09/1999 | EP0920867A1 Pyrido[2,3-a]pyrazine derivatives as PDE-IV and TNF inhibitors |
| 06/09/1999 | EP0920447A1 Process of purification of cyclosporin |
| 06/09/1999 | EP0920444A1 C-TERMINAL MODIFIED (N-SUBSTITUTED)-2-INDOLYL DIPEPTIDES AS INHIBITORS OF THE ICE/ced-3 FAMILY OF CYSTEINE PROTEASES |
| 06/09/1999 | EP0920428A1 Non-symmetrical bis-heteroarylmethoxyphenylalkyl carboxylates as inhibitors of leukotriene biosynthesis |
| 06/09/1999 | EP0920425A1 Substituted 4-(1h-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases |
| 06/09/1999 | EP0920422A1 Crytalline form of 4-[5-methyl-3-phenylisoxazol-4-yl]benzenesulfonamide |
| 06/09/1999 | EP0920334A1 Use of proteolytic enzymes for treating septic shock |
| 06/09/1999 | EP0920331A1 Treatment and prevention of infections, inflammations and/or tumours with lactoferrin and/or lactoferricin |
| 06/09/1999 | EP0920330A1 hCG AND DERIVATIVES AS MATRIX METALLOPROTEASES INHIBITORS |
| 06/09/1999 | EP0920322A1 Treatment of autoimmune diseases |
| 06/09/1999 | EP0784613B1 Colchicine derivatives and the therapeutical use thereof |
| 06/09/1999 | EP0763012B1 Succinyl hydroxamic acid, n-formyl-n-hydroxy amino carboxylic acid and succinic acid amide derivatives as metalloprotease inhibitors |
| 06/09/1999 | EP0751932B1 Vitamin-d amide derivatives |
| 06/09/1999 | EP0730598B1 Hindered esters of rapamycin and their use as pharmaceuticals |
| 06/09/1999 | CN1219171A Benzofuran carboxamides and their therapeutic use |
| 06/09/1999 | CN1218801A Tri-substituted imidazoles, and process of their preparation and using the same and having their pharmic composition |
| 06/09/1999 | CN1218692A Novel Anti-spasmodic composition and process for manufacture thereof |
| 06/08/1999 | US5910574 Human trk receptors and neurotrophic factor inhibitors |
| 06/08/1999 | US5910508 Novel compounds useful in modulating cellular hormone receptors; treating skin disorders such as acne, psoriasis |
| 06/08/1999 | US5910497 Treating acne vulgaris |
| 06/08/1999 | US5910437 Ligated d-protein of formula r-l-r' where r and r' are peptides and l is linking group of thiol ester or selenol ester; for production of chirally pure chemicals and drugs; production of racemic crystals; prolonged half-life in body |
| 06/08/1999 | US5910431 Polynucleotides encoding chemokine α-2 |
| 06/08/1999 | US5910430 Isolated nucleic acid encoding G-protein coupled receptor (HTADX50) |
| 06/08/1999 | US5910307 Process of extracting and purifying biologically effective ingredients from combined medicinal plants and their extract composition |
| 06/03/1999 | WO1999027127A1 NOVEL ribB |
| 06/03/1999 | WO1999027111A1 Desaturase genes and their use |
| 06/03/1999 | WO1999027098A2 A-33 related antigens and their pharmacological uses |
| 06/03/1999 | WO1999026961A1 Secreted proteins and polynucleotides encoding them |
| 06/03/1999 | WO1999026945A1 1,3,4-THIADIAZOLES AND 1,3,4-OXADIAZOLES AS αvβ3 ANTAGONISTS |
| 06/03/1999 | WO1999026944A1 New compounds which are p2-purinoceptor 7-transmembrane (tm) g-protein coupled receptor antagonists |
| 06/03/1999 | WO1999026942A1 5-(2-imidazolinylamino)-benzimidazole derivatives, their preparation and their use as .alpha.-adrenoceptor agonists with improved metabolic stability |
| 06/03/1999 | WO1999026924A1 Substituted oximes as neurokinin antagonists |
| 06/03/1999 | WO1999026921A1 SUBSTITUTED β-ALANINE DERIVATIVES AS CELL ADHESION INHIBITORS |
| 06/03/1999 | WO1999026909A2 Alpha-hydroxy, -amino and -fluoro derivatives of beta-sulphonyl hydroxamic acids as matrix metalloproteinases inhibitors |
| 06/03/1999 | WO1999026651A1 ribH |
| 06/03/1999 | WO1999026647A1 Use of heparin-binding protein for the modulation or prophylaxis of apoptosis of mammalian cells |
| 06/03/1999 | WO1999026628A1 Use of substituted 11-phenyl-dibenzazepine compounds for the treatment or prevention of sickle cell disease, inflammatory diseases characterized by abnormal cell proliferation, diarrhea and scour |
| 06/03/1999 | WO1999026624A1 Use of substituted diphenyl indanone, indane and indole compounds for the treatment or prevention of sickle cell disease, inflammatory diseases characterized by abnormal cell proliferation, diarrhe and scours |
| 06/03/1999 | WO1999026616A1 Benzenesulfonamide inhibitors of pde-iv and their therapeutic use |
| 06/03/1999 | WO1999026615A1 Cyclic amino acid derivatives as cell adhesion inhibitors |
| 06/03/1999 | WO1999012566A9 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF |
| 06/03/1999 | WO1999011275A3 Use of immunostimulatory oligonucleotides for preventing or reducing antigen-stimulated, granulocyte-mediated inflammation |
| 06/03/1999 | WO1999010312B1 N-alkanoylphenylalanine derivatives |
| 06/03/1999 | WO1999005096A3 Urokinase inhibitors |
| 06/03/1999 | CA2311683A1 Secreted proteins and polynucleotides encoding them |
| 06/03/1999 | CA2311472A1 Desaturase genes and their use |
| 06/03/1999 | CA2311129A1 Use of substituted diphenyl indanone, indane and indole compounds for the treatment or prevention of sickle cell disease, inflammatory diseases characterized by abnormal cell proliferation, diarrhea and scours |
| 06/03/1999 | CA2310773A1 Use of substituted 11-phenyl-dibenzazepine compounds for the treatment or prevention of sickle cell disease, inflammatory diseases characterized by abnormal cell proliferation, diarrhea and scour |
| 06/03/1999 | CA2310401A1 Alpha-hydroxy, -amino and -halo derivatives of beta-sulfone hydroxamates as matrix metalloproteinase inhibitors |
| 06/03/1999 | CA2309358A1 A-33 related antigens and their pharmacological uses |
| 06/03/1999 | CA2309341A1 Substituted .beta.-alanine derivatives as cell adhesion inhibitors |
| 06/03/1999 | CA2309338A1 Cyclic amino acid derivatives as cell adhesion inhibitors |
| 06/03/1999 | CA2309204A1 1,3,4-thiadiazoles and 1,3,4-oxadiazoles as .alpha.v.beta.3 antagonists |
| 06/02/1999 | EP0919544A1 Compounds useful for treating allergic and inflammatory diseases |
| 06/02/1999 | EP0919230A1 NMIFA's as anti-inflammatory agents in superficial mammal tissues |
| 06/02/1999 | EP0918860A2 Tumor necrosis factor-related polypeptide |
| 06/02/1999 | EP0918797A2 HUMANIZED IMMUNOGLOBULIN REACTIVE WITH $g(a)4$g(b)7 INTEGRIN |
| 06/02/1999 | EP0918795A1 Antiangiogenic drug to treat cancer, arthritis and retinopathy |
| 06/02/1999 | EP0918792A1 Dipeptide benzamidine as a kininogenase inhibitor |
| 06/02/1999 | EP0918787A1 Compositions and methods for antisense inhibition of protein translation |
| 06/02/1999 | EP0918747A1 INHIBITORS OF THE PRODUCTION OF s-CD23 AND THE SECRETION OF TNF |
| 06/02/1999 | EP0918746A1 Immunotherapeutic agents and their use in the reduction of cytokine levels |
| 06/02/1999 | EP0748310B1 Diesters of carbonic acid endowed with antiviral and anti-inflammatory activity |
| 06/02/1999 | EP0667854B1 Peptidyl activated ketone inhibitors containing natural and unnatural peptide sequences |
| 06/02/1999 | EP0625138B1 Novel amidine derivatives, their preparation and their use as medicaments with ltb4 antagonistic effect |
| 06/02/1999 | CN1218472A Pharmaceutically useful compounds |
| 06/02/1999 | CN1218459A 2-(3H)-oxazolene derivatives and their use as cox-2 inhibitors |
| 06/02/1999 | CN1218403A Formulation for use in prevention of pathogen induced diseases including HIV and HSV |
| 06/02/1999 | CN1218400A Cyclopentane heptan(ene) oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| 06/02/1999 | CN1218047A Novel imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them |
| 06/02/1999 | CN1218044A Urea derivatives |
| 06/02/1999 | CA2223075A1 Drug binding protein |
| 06/01/1999 | US5908858 1,2-diphenylpyrrole derivatives, their preparation and their therapeutic uses |